Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Evotec AG    EVT   DE0005664809

EVOTEC AG (EVT)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Evotec AG
Specializes in the discovery and development of new drugs

Evotec AG engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies.

It operates through the EVT Execute and EVT Innovate segments.

The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmes on a typical fee-for-service basis or through a variety of commercial structures, which may include research fees, milestones and royalties.

The EVT Innovate segment focuses on building a longterm partnered pharmaceutical pipeline from its own, internally developed assets and platforms.

The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.

Number of employees : 1 238 persons.
Sales per Businesses
20152016Delta
EUR (in Million)%EUR (in Million)%
EVT Execute106.2383.2%137.8583.8% +29.77%
EVT Innovate21.4516.8%26.6616.2% +24.26%
Sales per Regions
20152016Delta
EUR (in Million)%EUR (in Million)%
Europe72.7857%97.0659% +33.37%
United States53.6242%65.8040% +22.71%
Japan and Rest of the World1.281%1.651% +28.85%
Managers
NameAgeSinceTitle
Werner Lanthaler, PhD492009Chief Executive Officer
Wolfgang Plischke, PhD662014Chairman-Supervisory Board
Mario Polywka, PhD542004Chief Operating Officer
Enno Spillner, MBA472016Chief Financial Officer
Cord E. Dohrmann, PhD532010Chief Scientific Officer
Claus Tycho Bræstrup, MD722013Independent Member-Supervisory Board
Bernd Hirsch472013Vice Chairman-Supervisory Board
Iris Löw-Friedrich MD, PhD572014Independent Member-Supervisory Board
Elaine Sullivan, PhD562015Member-Supervisory Board
Michael Shalmi MD, MBA522017Member-Supervisory Board
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 147,494,037 133,844,122 90.7% 249,915 0.2% 90.7%
Shareholders
NameEquities%
Novo Nordisk Fonden 14,767,926 10.0%
Roland Oetker 13,400,000 9.11%
Allianz Global Investors GmbH 7,396,020 5.03%
Deutsche Asset Management Investment GmbH 5,169,174 3.51%
JPMorgan Asset Management (UK) Ltd. 4,869,421 3.31%
The Vanguard Group, Inc. 2,965,941 2.02%
Norges Bank Investment Management 2,371,757 1.61%
Goldman Sachs Asset Management LP 1,548,210 1.05%
Dimensional Fund Advisors LP 1,424,419 0.97%
BlackRock Asset Management Deutschland AG 1,308,419 0.89%
Holdings
NameEquities%Valuation
Evotec AG (EVT) 249,9150.17%5,935,581 USD
Company contact information
Evotec AG
Manfred Eigen Campus
Essener Bogen 7
Hamburg 22419

Phone : +49.40.56081.0
Fax : +49.40.56081.222
Web : www.evotec.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
EVOTEC AG152.15%3 261
INCYTE CORPORATION13.88%24 054
QUINTILES IMS HOLDINGS INC35.48%22 162
LONZA GROUP57.01%19 392
CELLTRION, INC.--.--%19 297
ALNYLAM PHARMACEUTICALS, INC.206.36%10 522
SEATTLE GENETICS, INC.21.02%9 134
IONIS PHARMACEUTICALS INC34.62%8 007
QIAGEN NV17.29%7 878
ALKERMES PLC-9.00%7 772
ICON PLC51.10%6 141
EXACT SCIENCES CORPORATION267.89%5 854
INC RESEARCH HOLDINGS INC6.18%5 782
CHARLES RIVER LABORATORIES INTL. INC51.16%5 481
UNITED THERAPEUTICS CORPORATION-15.63%5 257
PRA HEALTH SCIENCES INC50.36%5 193
GALAPAGOS41.24%5 159
BIO-TECHNE CORP20.83%4 646
PUMA BIOTECHNOLOGY INC306.03%4 638
ACADIA PHARMACEUTICALS INC.25.94%4 446
FIBROGEN INC155.37%4 316
Connections : Evotec AG
German Chemical Industry Fund
Bundesverband der Deutschen Industrie e.V.
Walter Siegenthaler Gesellschaft
IOLTECH SA
Robert Koch Stiftung eV
Momentum Gruppen A/S
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Technology Academy Finland
Forge Therapeutics, Inc.
Bayer Technology Services GmbH
Evotect (India) Pvt Ltd.
Bayer Real Estate GmbH
Bertelsmann, Inc.
Bayer Innovation GmbH
European Chemical Industry Council
Bankinvest Biomedical Venture
German Asia Pacific Business Association
The Royal Danish Scientific Society
University of Hohenheim
Paul Ehrlich-Foundation
Novo Large Investments
Penguin Random House LLC
Concentro Management AG
Penguin Random House Ltd.
Johann Wolfgang Goethe-Universität Frankfurt am Main
Hoechst Marion Roussel, Inc.
Eternygen GmbH
Carrick Therapeutics Ltd.
IP Group Plc /Venture Capital/
Aerocrine AB
Topas Therapeutics GmbH
Ataxion, Inc.
Synlab International GmbH
© 2017 People , Fundamentals and Ownership